- Home
- NMRA vs DSP Comparison
NMRA vs DSP Comparison
Compare NMRA & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- DSP
- Stock Information
- Founded
- NMRA 2019
- DSP 1999
- Country
- NMRA United States
- DSP United States
- Employees
- NMRA N/A
- DSP N/A
- Industry
- NMRA
- DSP EDP Services
- Sector
- NMRA
- DSP Technology
- Exchange
- NMRA Nasdaq
- DSP Nasdaq
- Market Cap
- NMRA 268.5M
- DSP 220.3M
- IPO Year
- NMRA 2023
- DSP 2021
- Fundamental
- Price
- NMRA $1.62
- DSP $9.73
- Analyst Decision
- NMRA Buy
- DSP Strong Buy
- Analyst Count
- NMRA 8
- DSP 9
- Target Price
- NMRA $7.14
- DSP $20.44
- AVG Volume (30 Days)
- NMRA 383.3K
- DSP 248.7K
- Earning Date
- NMRA 11-11-2025
- DSP 11-11-2025
- Dividend Yield
- NMRA N/A
- DSP N/A
- EPS Growth
- NMRA N/A
- DSP N/A
- EPS
- NMRA N/A
- DSP 0.13
- Revenue
- NMRA N/A
- DSP $318,471,000.00
- Revenue This Year
- NMRA N/A
- DSP $16.28
- Revenue Next Year
- NMRA N/A
- DSP $15.43
- P/E Ratio
- NMRA N/A
- DSP $74.73
- Revenue Growth
- NMRA N/A
- DSP 30.92
- 52 Week Low
- NMRA $0.61
- DSP $9.07
- 52 Week High
- NMRA $17.19
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- NMRA 47.71
- DSP 38.08
- Support Level
- NMRA $1.60
- DSP $9.63
- Resistance Level
- NMRA $1.70
- DSP $10.45
- Average True Range (ATR)
- NMRA 0.09
- DSP 0.37
- MACD
- NMRA -0.01
- DSP 0.11
- Stochastic Oscillator
- NMRA 8.51
- DSP 11.11
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.